S100A9 Exacerbates the Aβ1-42-mediated Innate Immunity in Human THP-1 Monocytes

E-ISSN： 1996-3181|15|8|910-917

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.15, Iss.8, 2016-09, pp. : 910-917

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial [Hot topic: Innate Immunity Molecules S100A8/A9 Involved in Stress Response and Cancer Biology (Guest Editors: Claus Kerkhoff and Saeid Ghavami)]

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 8, Iss. 4, 2009-12 ,pp. : 279-281

Bentham Science Publishers

Access to resources Recommend Favorite

Disposition and intracellular levels of moxifloxacin in human THP-1 monocytes in unstimulated and stimulated conditions

By Hall I.H. Schwab U.E. Ward E.S. Ives T.

International Journal of Antimicrobial Agents, Vol. 22, Iss. 6, 2003-12 ,pp. : 579-587

Elsevier

Access to resources Recommend Favorite

Intervention of Toll-like Receptor-Mediated Human Innate Immunity and Inflammation by Synthetic Compounds and Naturally Occurring Products

Current Medicinal Chemistry, Vol. 13, Iss. 12, 2006-05 ,pp. : 1389-1395

Bentham Science Publishers

Access to resources Recommend Favorite

Kaposi’s sarcoma-associated herpesvirus and innate immunity

By West John A Damania Blossom

Future Virology, Vol. 5, Iss. 2, 2010-03 ,pp. : 185-196

Future Medicine

Access to resources Recommend Favorite

Inhibition of l-leucine methyl ester mediated killing of THP-1, a human monocytic cell line, by a new anti-inflammatory drug, T614

By Sawada T. Hashimoto S. Tohma S. Nishioka Y. Nagai T. Sato T. Ito K. Inoue T. Iwata M. Yamamoto K.

Immunopharmacology, Vol. 49, Iss. 3, 2000-09 ,pp. : 285-294

Elsevier

Access to resources Recommend Favorite